Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petros P Sfikakis

Showing results (1-10 of 534) with videos related to

Pageof 54
Sort By:
Clinical Immunology (Orlando, Fla.)|October 15, 2011
Is IL-4 a potential therapeutic target in systemic sclerosis-associated pulmonary fibrosis?Petros P Sfikakis
Current Directions in Autoimmunity|February 23, 2010
The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directionsPetros P Sfikakis
RMD Open|August 16, 2019
Low rates of remission with methotrexate monotherapy in rheumatoid arthritis: review of randomised controlled trials could point towards a paradigm shiftKaterina Chatzidionysiou, Petros P Sfikakis
The Journal of Rheumatology|May 5, 2004
Ophthalmologic monitoring for antimalarial toxicityPetros P Sfikakis, Myron Mavrikakis
Current Opinion in Rheumatology|June 24, 2003
Tumor necrosis factor biology in experimental and clinical arthritisPetros P Sfikakis, George Kollias
Arthritis and Rheumatism|April 29, 2008
Tumor necrosis factor inhibitors and uveitis: comment on the article by Lim et alPetros P Sfikakis, Nikos Markomichelakis
Clinical and Experimental Rheumatology|October 1, 2014
Anti-cytokine biologic treatment beyond anti-TNF in Behçet's diseaseAikaterini Arida, Petros P Sfikakis
Hormones (Athens, Greece)|November 14, 2022
Cortisol and DHEAS in COVID-19Maria P Yavropoulou, Petros P Sfikakis
Clinical Immunology (Orlando, Fla.)|October 19, 2011
Towards the next generation of anti-TNF drugsPetros P Sfikakis, George C Tsokos
Mediterranean Journal of Rheumatology|March 19, 2020
Systemic lupus erythematosus with antiphospholipid syndrome: Cardiovascular magnetic resonance for evaluation of cardiac hypertrophySophie I Mavrogeni, Petros P Sfikakis
Pageof 54

Showing results (1-10 of 534) with videos related to

Sort By:
Pageof 54
Clinical Immunology (Orlando, Fla.)|October 15, 2011
Is IL-4 a potential therapeutic target in systemic sclerosis-associated pulmonary fibrosis?Petros P Sfikakis
Current Directions in Autoimmunity|February 23, 2010
The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directionsPetros P Sfikakis
RMD Open|August 16, 2019
Low rates of remission with methotrexate monotherapy in rheumatoid arthritis: review of randomised controlled trials could point towards a paradigm shiftKaterina Chatzidionysiou, Petros P Sfikakis
The Journal of Rheumatology|May 5, 2004
Ophthalmologic monitoring for antimalarial toxicityPetros P Sfikakis, Myron Mavrikakis
Current Opinion in Rheumatology|June 24, 2003
Tumor necrosis factor biology in experimental and clinical arthritisPetros P Sfikakis, George Kollias
Arthritis and Rheumatism|April 29, 2008
Tumor necrosis factor inhibitors and uveitis: comment on the article by Lim et alPetros P Sfikakis, Nikos Markomichelakis
Clinical and Experimental Rheumatology|October 1, 2014
Anti-cytokine biologic treatment beyond anti-TNF in Behçet's diseaseAikaterini Arida, Petros P Sfikakis
Hormones (Athens, Greece)|November 14, 2022
Cortisol and DHEAS in COVID-19Maria P Yavropoulou, Petros P Sfikakis
Clinical Immunology (Orlando, Fla.)|October 19, 2011
Towards the next generation of anti-TNF drugsPetros P Sfikakis, George C Tsokos
Mediterranean Journal of Rheumatology|March 19, 2020
Systemic lupus erythematosus with antiphospholipid syndrome: Cardiovascular magnetic resonance for evaluation of cardiac hypertrophySophie I Mavrogeni, Petros P Sfikakis
Pageof 54